BioSpace News Archive

Mind Medicine today announced that members of MindMed’s management team will participate in the Canaccord Genuity 42nd Annual Growth Conference.

Miravo Healthcare™ Announces Second Quarter 2022 Results Release Date and Conference Call Details.

Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that it will host a live conference call and webcast at 8:30 a.m. ET on Tuesday, August 9, 2022 to report its second quarter 2022 financial results and provide a corporate update.

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading provider of surgical services, today announced results for the second quarter ended June 30, 2022.

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:00 a.m. ET on Tuesday, August 9, 2022, to provide a corporate update and discuss the Company’s financial results for the second quarter ended June 30, 2022.

Pliant Therapeutics, Inc. today announced that Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer, will participate in a panel discussion at the BTIG Biotechnology Conference 2022.

Magenta Therapeutics today announced that the company will participate in a Gene Modulation Panel Discussion at the 2022 Wedbush PacGrow Healthcare Conference, to be held virtually, on Tuesday, August 9th, 2022 at 9:45 a.m. ET.

C4 Therapeutics, Inc. today announced the appointments of Laura Bessen, M.D. and Donna Grogan, M.D. to its board of directors.

Impel Pharmaceuticals Inc. today announced that Adrian Adams, Chairman and Chief Executive Officer, and John Leaman, M.D., Chief Financial and Business Officer, will participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Conference.

Aprea Therapeutics, Inc. today announced that Oren Gilad Ph.D, President and Chief Executive Officer, will participate in a panel discussion on synthetic lethality at the 2022 Wedbush PacGrow Healthcare Conference on Tuesday, August 9, 2022 at 12:35 p.m. ET.